These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Lanes R; Recker B; Fort P; Lifshitz F Diabetes; 1985 Feb; 34(2):156-60. PubMed ID: 3967801 [TBL] [Abstract][Full Text] [Related]
3. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem? Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569 [TBL] [Abstract][Full Text] [Related]
4. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941 [TBL] [Abstract][Full Text] [Related]
5. Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus. Nieves-Rivera F; Rogol AD; Veldhuis JD; Branscom DK; Martha PM; Clarke WL J Clin Endocrinol Metab; 1993 Sep; 77(3):638-43. PubMed ID: 8370685 [TBL] [Abstract][Full Text] [Related]
6. Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Salardi S; Cacciari E; Ballardini D; Righetti F; Capelli M; Cicognani A; Zucchini S; Natali G; Tassinari D Diabetes; 1986 Jul; 35(7):832-6. PubMed ID: 3721066 [TBL] [Abstract][Full Text] [Related]
7. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. Hilding A; Brismar K; Degerblad M; Thorén M; Hall K J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695 [TBL] [Abstract][Full Text] [Related]
8. Growth parameters, growth hormone (GH) response to clonidine and circulating insulin-like growth factor-I (IGF-I), free thyroxine (FT4) and cortisol concentrations in relation to glycaemic control in children with insulin-dependent diabetes mellitus. Soliman AT; Ahmed HI; Asfour MG J Trop Pediatr; 1996 Aug; 42(4):228-32. PubMed ID: 8816035 [TBL] [Abstract][Full Text] [Related]
9. The effect of small but sustained elevations in circulating growth hormone on fuel metabolism in growth hormone deficiency. Tamborlane WV; Genel M; Gianfredi S; Gertner JM Pediatr Res; 1984 Feb; 18(2):212-5. PubMed ID: 6366723 [TBL] [Abstract][Full Text] [Related]
10. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous and stimulated growth hormone release in adolescents with type I diabetes mellitus: effects of metabolic control. Miller JD; Wright NM; Lester SE; Felsing NE; Linzer J; Chan E; White DA; Charles MA J Clin Endocrinol Metab; 1992 Oct; 75(4):1087-91. PubMed ID: 1400876 [TBL] [Abstract][Full Text] [Related]
12. Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus. Correlation with changes in somatogenic and lactogenic liver binding sites. Maes M; Ketelslegers JM; Underwood LE Diabetes; 1983 Nov; 32(11):1060-9. PubMed ID: 6315512 [TBL] [Abstract][Full Text] [Related]
13. The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I). Cheetham TD; Connors M; Clayton K; Watts A; Dunger DB Clin Endocrinol (Oxf); 1997 Apr; 46(4):415-24. PubMed ID: 9196603 [TBL] [Abstract][Full Text] [Related]
14. Fasting growth hormone levels in diabetes mellitus. Nazaimoon WM; Ng ML; Khalid BA Ann Acad Med Singap; 1993 Nov; 22(6):861-3. PubMed ID: 8129344 [TBL] [Abstract][Full Text] [Related]
15. Exaggerated somatomedin-C response to human growth hormone infusion in patients with type II diabetes mellitus. Grecu EO; Spencer EM; White VA; Sheikholislam BM Am J Med Sci; 1984; 287(2):7-10. PubMed ID: 6538751 [TBL] [Abstract][Full Text] [Related]
16. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion. Rappaport R; Prevot C; Brauner R J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478 [TBL] [Abstract][Full Text] [Related]
17. Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. Vermeulen A J Clin Endocrinol Metab; 1987 May; 64(5):884-8. PubMed ID: 3558729 [TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children. Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475 [TBL] [Abstract][Full Text] [Related]
19. Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus. Salgado LR; Semer M; Nery M; Knoepfelmacher M; Lerário AC; Póvoa G; Jana S; Villares SM; Wajchenberg BL; Liberman B; Nicolau W J Endocrinol Invest; 1996; 19(7):433-40. PubMed ID: 8884537 [TBL] [Abstract][Full Text] [Related]
20. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty. Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]